This health education program aims to help patients living with COPD experience better health outcomes and improved quality ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

The EMA has agreed to review GSK’s application to expand Nucala’s use as an add-on maintenance for individuals with COPD.

The systemic immune response index outperformed other inflammatory markers in predicting chronic obstructive pulmonary ...

Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung tissue.

The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Adults who had an above-average BMI, overweight or obesity during childhood have increased risk for developing chronic ...

This interactive map explains where COPD rates, hospitalizations, and deaths are highest across the United States.

Adults with arthritis and chronic obstructive pulmonary disease (COPD) have a higher risk for mortality than indivi ...

Adrina didn’t realize lung disease was so prevalent until she joined a Walk and learned more about lung disease. Now she is a ...

Genetic factors may affect the functional status of patients with chronic obstructive pulmonary disease (COPD).